Compare NXL & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXL | SEED |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 12.3M |
| IPO Year | 2022 | 2005 |
| Metric | NXL | SEED |
|---|---|---|
| Price | $0.37 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 220.5K | 58.7K |
| Earning Date | 05-11-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $301,647.00 | N/A |
| Revenue This Year | $15.52 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 78.78 | N/A |
| 52 Week Low | $0.31 | $0.87 |
| 52 Week High | $2.00 | $2.49 |
| Indicator | NXL | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 63.63 |
| Support Level | $0.34 | $1.07 |
| Resistance Level | $0.49 | $1.47 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 21.86 | 79.30 |
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.